1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of GCK mRNA CTD PMID:22206623 1-methylphenanthrene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of GCK mRNA CTD PMID:17690111 1-naphthyl isothiocyanate decreases expression ISO RGD:2670 6480464 1-Naphthylisothiocyanate results in decreased expression of GCK mRNA CTD PMID:17522070 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GCK mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:2670 6480464 Estradiol results in decreased expression of GCK mRNA CTD PMID:22946080 17beta-estradiol increases expression ISO RGD:735697 6480464 Estradiol results in increased expression of GCK mRNA CTD PMID:31614463 1H-pyrazole decreases expression EXP 6480464 pyrazole results in decreased expression of GCK mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GCK mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GCK mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GCK mRNA CTD PMID:18343893 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2670 6480464 Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA CTD PMID:16054898 , PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2670 6480464 Tetrachlorodibenzodioxin results in increased expression of GCK mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2670 6480464 Tetrachlorodibenzodioxin affects the expression of GCK mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2670 6480464 AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of GCK mRNA] CTD PMID:21215274 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:25768209 2,3,7,8-Tetrachlorodibenzofuran affects expression EXP 6480464 2 more ... CTD PMID:18343893 2,4,6-trinitrotoluene affects expression ISO RGD:2670 6480464 Trinitrotoluene affects the expression of GCK mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression ISO RGD:2670 6480464 2, 4-dinitrotoluene affects the expression of GCK mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:2670 6480464 2, 6-dinitrotoluene affects the expression of GCK mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:2670 6480464 Glucosamine results in decreased expression of GCK mRNA CTD PMID:11893929 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:2670 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol increases expression ISO RGD:2670 6480464 alpha-Chlorohydrin results in increased expression of GCK mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GCK mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:735697 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GCK mRNA CTD PMID:31121516 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:735697 6480464 6-chloro-2 more ... CTD PMID:21163946 6-propyl-2-thiouracil increases expression ISO RGD:2670 6480464 Propylthiouracil results in increased expression of GCK mRNA CTD PMID:24780913 8-Br-cAMP decreases expression ISO RGD:735697 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GCK mRNA CTD PMID:22079614 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of GCK mRNA CTD PMID:21670153 9-cis-retinoic acid decreases activity ISO RGD:2670 6480464 Alitretinoin results in decreased activity of GCK protein CTD PMID:21115832 aconitine increases expression ISO RGD:2670 6480464 Aconitine results in increased expression of GCK protein CTD PMID:33236894 acrylamide decreases expression ISO RGD:2670 6480464 Acrylamide results in decreased expression of GCK mRNA CTD PMID:31644924 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of GCK mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:2670 6480464 Aflatoxin B1 results in increased expression of GCK mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:735697 6480464 Aflatoxin B1 results in increased methylation of GCK exon CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:735697 6480464 Aflatoxin B1 results in decreased expression of GCK mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:735697 6480464 Aflatoxin B1 results in decreased methylation of GCK gene CTD PMID:27153756 aldehydo-D-glucosamine decreases expression ISO RGD:2670 6480464 Glucosamine results in decreased expression of GCK mRNA CTD PMID:11893929 aldehydo-D-glucose multiple interactions EXP 6480464 [ebselen co-treated with Glucose] results in increased activity of GCK protein, Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA] CTD PMID:12137914 , PMID:23795780 aldehydo-D-glucose decreases expression ISO RGD:2670 6480464 Glucose results in decreased expression of GCK mRNA CTD PMID:31974165 aldehydo-D-glucose multiple interactions ISO RGD:2670 6480464 Glucose results in decreased expression of and affects the localization of GCK protein, Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA] CTD PMID:31974165 aldehydo-D-glucose increases expression ISO RGD:2670 6480464 Glucose results in increased expression of GCK mRNA CTD PMID:24349266 all-trans-retinoic acid affects expression ISO RGD:735697 6480464 Tretinoin affects the expression of GCK mRNA CTD PMID:34742744 alloxan decreases expression EXP 6480464 Alloxan results in decreased expression of GCK mRNA, Alloxan results in decreased expression of GCK protein CTD PMID:12137914 , PMID:26827782 alloxan multiple interactions ISO RGD:2670 6480464 ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK mRNA], ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK protein] CTD PMID:33359794 alloxan decreases expression ISO RGD:2670 6480464 Alloxan results in decreased expression of GCK mRNA, Alloxan results in decreased expression of GCK protein CTD PMID:33359794 alloxan multiple interactions EXP 6480464 Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA], Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCK protein] CTD PMID:12137914 , PMID:26827782 ammonium chloride affects expression ISO RGD:2670 6480464 Ammonium Chloride affects the expression of GCK mRNA CTD PMID:16483693 anthracen-2-amine increases expression ISO RGD:2670 6480464 2-anthramine results in increased expression of GCK mRNA CTD PMID:23038007 arsane increases methylation ISO RGD:735697 6480464 Arsenic results in increased methylation of GCK promoter CTD PMID:21291286 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of GCK protein CTD PMID:32226249 arsenic atom increases methylation ISO RGD:735697 6480464 Arsenic results in increased methylation of GCK promoter CTD PMID:21291286 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of GCK protein CTD PMID:32226249 arsenous acid multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased activity of GCK protein], Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of GCK mRNA] CTD PMID:30362509 , PMID:32226249 arsenous acid multiple interactions ISO RGD:735697 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GCK protein] CTD PMID:26598702 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of GCK mRNA CTD PMID:30362509 atorvastatin calcium decreases expression ISO RGD:735697 6480464 Atorvastatin results in decreased expression of GCK protein CTD PMID:26616219 atorvastatin calcium multiple interactions ISO RGD:735697 6480464 NR1I2 protein promotes the reaction [Atorvastatin results in decreased expression of GCK protein] CTD PMID:26616219 atorvastatin calcium decreases expression ISO RGD:2670 6480464 Atorvastatin results in decreased expression of GCK protein CTD PMID:26616219 benzamide increases activity ISO RGD:735697 6480464 benzamide analog results in increased activity of GCK protein CTD PMID:19758809 benzene increases expression EXP 6480464 Benzene results in increased expression of GCK mRNA CTD PMID:33502539 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GCK mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:735697 6480464 Benzo(a)pyrene affects the methylation of GCK promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[b]fluoranthene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GCK mRNA CTD PMID:17690111 beta-D-glucosamine decreases expression ISO RGD:2670 6480464 Glucosamine results in decreased expression of GCK mRNA CTD PMID:11893929 beta-naphthoflavone multiple interactions ISO RGD:2670 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GCK mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of GCK mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of GCK protein CTD PMID:33484791 bis(2-ethylhexyl) phthalate decreases activity ISO RGD:2670 6480464 Diethylhexyl Phthalate results in decreased activity of GCK protein CTD PMID:25280772 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:2670 6480464 Diethylhexyl Phthalate results in decreased expression of GCK mRNA CTD PMID:25280772 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GCK mRNA, bisphenol A results in increased expression of GCK protein CTD PMID:21932408 more ... bisphenol A decreases expression ISO RGD:735697 6480464 bisphenol A results in decreased expression of GCK mRNA CTD PMID:31121516 bisphenol A decreases expression ISO RGD:2670 6480464 bisphenol A results in decreased expression of GCK mRNA CTD PMID:22946080 more ... bisphenol A multiple interactions ISO RGD:2670 6480464 [bisphenol A results in increased methylation of GCK promoter] which results in decreased expression of GCK mRNA CTD PMID:23748860 bisphenol A increases methylation ISO RGD:2670 6480464 bisphenol A results in increased methylation of GCK gene, bisphenol A results in increased methylation of GCK promoter CTD PMID:23748860 more ... bisphenol F decreases expression ISO RGD:735697 6480464 bisphenol F results in decreased expression of GCK mRNA CTD PMID:31121516 bisphenol F multiple interactions ISO RGD:735697 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of GCK gene CTD PMID:31601247 boric acid increases expression EXP 6480464 boric acid results in increased expression of GCK mRNA CTD PMID:31368021 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of GCK mRNA CTD PMID:25620056 chloroform increases expression ISO RGD:2670 6480464 Chloroform results in increased expression of GCK mRNA CTD PMID:17522070 chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of GCK mRNA CTD PMID:33246813 chlorothalonil multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GCK mRNA CTD PMID:33246813 choline multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of GCK mRNA, [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:29127188 , PMID:33549593 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of GCK mRNA CTD PMID:18353800 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA] CTD PMID:17585979 copper atom decreases expression EXP 6480464 Copper results in decreased expression of GCK mRNA CTD PMID:17205981 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of GCK mRNA CTD PMID:17205981 Cuprizon decreases expression ISO RGD:2670 6480464 Cuprizone results in decreased expression of GCK mRNA CTD PMID:27523638 cyanocob(III)alamin multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:33549593 cyclosporin A increases methylation ISO RGD:735697 6480464 Cyclosporine results in increased methylation of GCK promoter CTD PMID:27989131 D-glucose multiple interactions EXP 6480464 [ebselen co-treated with Glucose] results in increased activity of GCK protein, Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA] CTD PMID:12137914 , PMID:23795780 D-glucose multiple interactions ISO RGD:2670 6480464 Glucose results in decreased expression of and affects the localization of GCK protein, Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA] CTD PMID:31974165 D-glucose decreases expression ISO RGD:2670 6480464 Glucose results in decreased expression of GCK mRNA CTD PMID:31974165 D-glucose increases expression ISO RGD:2670 6480464 Glucose results in increased expression of GCK mRNA CTD PMID:24349266 desferrioxamine B affects expression ISO RGD:2670 6480464 Deferoxamine affects the expression of GCK mRNA CTD PMID:9761743 dexamethasone increases expression ISO RGD:2670 6480464 Dexamethasone results in increased expression of GCK mRNA CTD PMID:17522070 dexamethasone decreases expression ISO RGD:2670 6480464 Dexamethasone results in decreased expression of GCK mRNA CTD PMID:31778773 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of GCK mRNA CTD PMID:30362509 diarsenic trioxide multiple interactions ISO RGD:735697 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GCK protein] CTD PMID:26598702 diarsenic trioxide multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased activity of GCK protein], Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of GCK mRNA] CTD PMID:30362509 , PMID:32226249 dibenz[a,h]anthracene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] affects the expression of GCK mRNA CTD PMID:17690111 dichlorvos decreases activity ISO RGD:2670 6480464 Dichlorvos results in decreased activity of GCK protein CTD PMID:16153661 dichlorvos increases expression ISO RGD:2670 6480464 Dichlorvos results in increased expression of GCK mRNA CTD PMID:16153661 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of GCK mRNA CTD PMID:26934552 diethylstilbestrol decreases expression ISO RGD:2670 6480464 Diethylstilbestrol results in decreased expression of GCK mRNA CTD PMID:22946080 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of GCK mRNA CTD PMID:24205000 duvoglustat multiple interactions EXP 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK protein] CTD PMID:25446853 ebselen multiple interactions EXP 6480464 [ebselen co-treated with Glucose] results in increased activity of GCK protein CTD PMID:23795780 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of GCK mRNA CTD PMID:35436446 erythromycin estolate decreases expression ISO RGD:2670 6480464 Erythromycin Estolate results in decreased expression of GCK mRNA CTD PMID:17522070 ethanol multiple interactions EXP 6480464 5-aminoisoquinolinone inhibits the reaction [Ethanol results in increased expression of GCK mRNA] more ... CTD PMID:27984176 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GCK mRNA CTD PMID:27984176 fluoranthene multiple interactions ISO RGD:735697 6480464 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GCK mRNA CTD PMID:17690111 folic acid multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of GCK mRNA, [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:29127188 , PMID:33549593 folic acid decreases expression ISO RGD:735697 6480464 Folic Acid results in decreased expression of GCK mRNA CTD PMID:21867686 fructose increases activity ISO RGD:2670 6480464 Fructose results in increased activity of GCK protein CTD PMID:20470786 fulvestrant multiple interactions ISO RGD:735697 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of GCK gene CTD PMID:31601247 furan increases methylation ISO RGD:2670 6480464 furan results in increased methylation of GCK gene CTD PMID:22079235 furan decreases expression ISO RGD:2670 6480464 furan results in decreased expression of GCK mRNA CTD PMID:25539665 gamma-hexachlorocyclohexane increases expression ISO RGD:2670 6480464 Hexachlorocyclohexane results in increased expression of GCK mRNA CTD PMID:17785943 Ginsenoside Rh4 multiple interactions ISO RGD:2670 6480464 ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK mRNA], ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK protein] CTD PMID:33359794 Ginsenoside Rh4 multiple interactions EXP 6480464 ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK mRNA] CTD PMID:33359794 glafenine increases expression ISO RGD:2670 6480464 Glafenine results in increased expression of GCK mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 [ebselen co-treated with Glucose] results in increased activity of GCK protein, Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA] CTD PMID:12137914 , PMID:23795780 glucose decreases expression ISO RGD:2670 6480464 Glucose results in decreased expression of GCK mRNA CTD PMID:31974165 glucose multiple interactions ISO RGD:2670 6480464 Glucose results in decreased expression of and affects the localization of GCK protein, Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA] CTD PMID:31974165 glucose increases expression ISO RGD:2670 6480464 Glucose results in increased expression of GCK mRNA CTD PMID:24349266 glycine betaine multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:33549593 hesperidin multiple interactions EXP 6480464 Hesperidin affects the reaction [LEPR protein affects the expression of GCK mRNA] CTD PMID:16427799 hydrazine decreases expression ISO RGD:2670 6480464 hydrazine results in decreased expression of GCK mRNA CTD PMID:15370871 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCK mRNA CTD PMID:36331819 L-methionine multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of GCK mRNA, [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:29127188 , PMID:33549593 metformin affects expression ISO RGD:2670 6480464 Metformin affects the expression of GCK mRNA CTD PMID:31324951 metformin multiple interactions ISO RGD:735697 6480464 Metformin inhibits the reaction [INS protein results in decreased activity of GCK protein], Metformin inhibits the reaction [INS protein results in decreased expression of GCK protein] CTD PMID:33651899 metformin multiple interactions ISO RGD:2670 6480464 Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA] CTD PMID:31974165 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of GCK mRNA CTD PMID:34813904 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of GCK protein CTD PMID:27178136 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of GCK mRNA CTD PMID:17654400 , PMID:25497113 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:735697 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of GCK protein CTD PMID:31228551 monocrotophos increases activity ISO RGD:2670 6480464 Monocrotophos results in increased activity of GCK protein CTD PMID:32267039 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions EXP 6480464 N-(3, 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Particulate Matter results in increased expression of GCK mRNA] CTD PMID:29635361 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of GCK exon, Ethylnitrosourea results in increased mutagenesis of GCK gene CTD PMID:15102714 more ... N-nitrosodiethylamine multiple interactions ISO RGD:2670 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GCK mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GCK mRNA CTD PMID:18164116 , PMID:28943392 N-nitrosodimethylamine decreases expression ISO RGD:2670 6480464 Dimethylnitrosamine results in decreased expression of GCK mRNA CTD PMID:17072980 N-nitrosomorpholine decreases expression ISO RGD:2670 6480464 N-nitrosomorpholine results in decreased expression of GCK mRNA, N-nitrosomorpholine results in decreased expression of GCK protein CTD PMID:19716841 naringin multiple interactions EXP 6480464 naringin affects the reaction [LEPR protein affects the expression of GCK mRNA] CTD PMID:16427799 nefazodone decreases expression ISO RGD:2670 6480464 nefazodone results in decreased expression of GCK mRNA CTD PMID:24136188 Nonylphenol decreases expression ISO RGD:2670 6480464 nonylphenol results in decreased expression of GCK mRNA CTD PMID:22946080 ozone decreases expression ISO RGD:2670 6480464 Ozone results in decreased expression of GCK mRNA CTD PMID:25838073 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GCK mRNA CTD PMID:17562736 penconazole increases expression EXP 6480464 penconazole results in increased expression of GCK mRNA CTD PMID:31733957 perfluorononanoic acid decreases expression ISO RGD:2670 6480464 perfluoro-n-nonanoic acid results in decreased expression of GCK mRNA CTD PMID:22387981 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of GCK mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCK mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:2670 6480464 perfluorooctane sulfonic acid results in decreased expression of GCK mRNA CTD PMID:19162173 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of GCK mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GCK protein CTD PMID:28947262 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of GCK mRNA CTD PMID:23626681 perfluorooctanoic acid multiple interactions EXP 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of GCK mRNA] CTD PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:2670 6480464 perfluorooctanoic acid results in decreased expression of GCK mRNA CTD PMID:19162173 phenformin decreases expression ISO RGD:2670 6480464 Phenformin results in decreased expression of GCK mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:2670 6480464 Phenobarbital results in decreased expression of GCK mRNA CTD PMID:19162173 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of GCK mRNA CTD PMID:20813756 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of GCK mRNA CTD PMID:15302862 more ... pravastatin decreases expression ISO RGD:2670 6480464 Pravastatin results in decreased expression of GCK mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:2670 6480464 Pregnenolone Carbonitrile results in decreased expression of GCK protein CTD PMID:26616219 procymidone multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GCK mRNA CTD PMID:33246813 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of GCK mRNA CTD PMID:33246813 Repaglinide increases expression ISO RGD:2670 6480464 repaglinide analog results in increased expression of GCK mRNA CTD PMID:35702883 Repaglinide multiple interactions ISO RGD:2670 6480464 repaglinide analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK mRNA], repaglinide inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK mRNA] CTD PMID:35702883 resveratrol multiple interactions ISO RGD:2670 6480464 [resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein]] which results in decreased expression of GCK mRNA more ... CTD PMID:16626303 , PMID:19740748 resveratrol decreases expression ISO RGD:2670 6480464 resveratrol results in decreased expression of GCK mRNA, resveratrol results in decreased expression of GCK protein CTD PMID:19740748 resveratrol decreases activity ISO RGD:2670 6480464 resveratrol results in decreased activity of GCK protein CTD PMID:19740748 resveratrol increases expression ISO RGD:735697 6480464 resveratrol results in increased expression of GCK mRNA CTD PMID:21163946 resveratrol multiple interactions ISO RGD:735697 6480464 6-chloro-2 more ... CTD PMID:21163946 rifampicin decreases expression ISO RGD:735697 6480464 Rifampin results in decreased expression of GCK protein CTD PMID:26616219 rifampicin multiple interactions ISO RGD:735697 6480464 NR1I2 protein promotes the reaction [Rifampin results in decreased expression of GCK protein] CTD PMID:26616219 rotenone decreases expression ISO RGD:2670 6480464 Rotenone results in decreased expression of GCK mRNA CTD PMID:28374803 selenomethionine increases expression EXP 6480464 Selenomethionine results in increased expression of GCK mRNA CTD PMID:28810182 sevoflurane affects expression ISO RGD:2670 6480464 sevoflurane affects the expression of GCK mRNA CTD PMID:15967596 sodium arsenite increases expression ISO RGD:735697 6480464 sodium arsenite results in increased expression of GCK mRNA CTD PMID:23648393 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of GCK protein, Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased activity of GCK protein] CTD PMID:32226249 sodium arsenite decreases expression ISO RGD:735697 6480464 sodium arsenite results in decreased expression of GCK mRNA CTD PMID:29301061 streptozocin multiple interactions ISO RGD:2670 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK mRNA more ... CTD PMID:27038876 , PMID:35702883 streptozocin multiple interactions EXP 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCK protein] more ... CTD PMID:25446853 more ... streptozocin decreases expression ISO RGD:2670 6480464 Streptozocin results in decreased expression of GCK mRNA CTD PMID:27038876 styrene increases expression ISO RGD:2670 6480464 Styrene results in increased expression of GCK mRNA CTD PMID:28678435 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of GCK mRNA CTD PMID:20937368 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of GCK mRNA] CTD PMID:30362509 testosterone increases expression EXP 6480464 Testosterone results in increased expression of GCK mRNA CTD PMID:20403060 tetrachloromethane decreases expression ISO RGD:2670 6480464 Carbon Tetrachloride results in decreased expression of GCK mRNA CTD PMID:17522070 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of GCK mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GCK mRNA CTD PMID:27339419 thapsigargin increases expression ISO RGD:2670 6480464 Thapsigargin results in increased expression of GCK protein CTD PMID:35544339 theophylline increases expression ISO RGD:2670 6480464 Theophylline results in increased expression of GCK mRNA CTD PMID:17522070 thioacetamide decreases expression ISO RGD:2670 6480464 Thioacetamide results in decreased expression of GCK mRNA CTD PMID:23411599 thioacetamide multiple interactions ISO RGD:2670 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GCK mRNA CTD PMID:28943392 Triptolide decreases expression ISO RGD:2670 6480464 triptolide results in decreased expression of GCK mRNA CTD PMID:23639586 triptonide increases expression EXP 6480464 triptonide results in increased expression of GCK mRNA CTD PMID:33045310 valproic acid decreases expression ISO RGD:735697 6480464 Valproic Acid results in decreased expression of GCK mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:735697 6480464 Valproic Acid affects the expression of GCK mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:735697 6480464 Valproic Acid results in increased methylation of GCK gene CTD PMID:29154799 vanillic acid multiple interactions ISO RGD:735697 6480464 Vanillic Acid inhibits the reaction [INS protein results in decreased activity of GCK protein], Vanillic Acid inhibits the reaction [INS protein results in decreased expression of GCK protein] CTD PMID:33651899 WIN 55212-2 increases expression EXP 6480464 (3R)-((2 more ... CTD PMID:12237329 zaragozic acid A decreases expression ISO RGD:2670 6480464 squalestatin 1 results in decreased expression of GCK mRNA CTD PMID:27225895 zinc atom multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:33549593 zinc(0) multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA CTD PMID:33549593